BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11756856)

  • 81. Accumulation of methotrexate in systemic tissues after intrathecal administration.
    Bleyer WA; Nelson JA; Kamen BA
    J Pediatr Hematol Oncol; 1997; 19(6):530-2. PubMed ID: 9407940
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Central nervous system prophylaxis with high-dose methotrexate does not give rise to significant electroencephalographic changes in children with acute lymphoblastic leukemia.
    Korinthenberg R; Schneider A; Niemeyer C
    J Child Neurol; 2002 Jun; 17(6):409-12. PubMed ID: 12174959
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Methotrexate-induced toxic leukoencephalopathy.
    Gowan GM; Herrington JD; Simonetta AB
    Pharmacotherapy; 2002 Sep; 22(9):1183-7. PubMed ID: 12222556
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
    Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
    Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young children.
    Seidel H; Nygaard R; Haave I; Moe PJ
    Acta Paediatr; 1996 Apr; 85(4):450-3. PubMed ID: 8740303
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
    Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Primary CNS lymphoma: a clinician's guide.
    Schäfer N; Glas M; Herrlinger U
    Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Leukoencephalopathy complicating an Ommaya reservoir and chemotherapy.
    Stone JA; Castillo M; Mukherji SK
    Neuroradiology; 1999 Feb; 41(2):134-6. PubMed ID: 10090607
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model.
    Lesnik PG; Ciesielski KT; Hart BL; Benzel EC; Sanders JA
    Arch Neurol; 1998 Dec; 55(12):1561-8. PubMed ID: 9865801
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Rechallenging With Intrathecal Methotrexate After Developing Subacute Neurotoxicity in Children With Hematologic Malignancies.
    Badke C; Fleming A; Iqbal A; Khilji O; Parhas S; Weinstein J; Morgan E; Hijiya N
    Pediatr Blood Cancer; 2016 Apr; 63(4):723-6. PubMed ID: 26681571
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Primary brain T-cell lymphoma of the lymphoblastic type presenting as altered mental status.
    Clark AJ; Lee K; Broaddus WC; Martin MJ; Ghatak NR; Grossman CE; Baker S; Baykal A
    Acta Neurochir (Wien); 2010 Jan; 152(1):163-8. PubMed ID: 19578806
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chronic methotrexate toxicity to the central nervous system.
    Shapiro WR; Allen JC; Horten BC
    Clin Bull; 1980; 10(2):49-52. PubMed ID: 6893169
    [No Abstract]   [Full Text] [Related]  

  • 94. Bilateral optic nerve infiltration in central nervous system leukemia.
    Schocket LS; Massaro-Giordano M; Volpe NJ; Galetta SL
    Am J Ophthalmol; 2003 Jan; 135(1):94-6. PubMed ID: 12504706
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Myelopathy following intrathecal chemotherapy in adults: a single institution experience.
    Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K
    J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Chiasmal compression. Presenting ocular features.
    Wybar K
    Proc R Soc Med; 1977 May; 70(5):307-17. PubMed ID: 877095
    [No Abstract]   [Full Text] [Related]  

  • 97. [Primitif cerebral lymphoma].
    Benouaich-Amiel A; Kaloshi G; Khe HX
    Rev Prat; 2006 Oct; 56(16):1787-91. PubMed ID: 17315504
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Neurological complications of neurooncological therapy].
    Herrlinger U; Steinbach JP
    Nervenarzt; 2010 Aug; 81(8):940-9. PubMed ID: 20635073
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Primary diffuse large B cell lymphoma of the optic chiasm in an immunocompetent patient.
    De Jesus O; Rios-Vicil C; Gómez-González FM; Vélez R
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330724
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [A case of intraventricular dissemination arising from hepatocelullar carcinoma effectively treated with intrathecal administration of methotrexate].
    Oguri H; Miyazawa M; Nishikawa T; Hayashi S
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jun; 111(6):1120-7. PubMed ID: 24898491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.